Company Search:
Advanced Search
Sponsored Links
BioPorto A/S Company Snapshot
BioPorto A/S operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares BioPorto A/S with three other pharmaceutical manufacturers in Europe: Addex Therapeutics of SWITZERLAND (2019 sales of 2.83 million Swiss Francs [US$3.09 million] of which 100% was Pharmaceuticals Manufacture), Collagen Solutions PLC of UNITED KINGDOM (£4.15 million [US$5.43 million] of which 100% was Biomaterials), and Onxeo SA which is based in FRANCE (4.29 million Euros [US$5.03 million] of which 82% was Oncology products).

Sales Analysis. BioPorto A/S reported sales of 26.62 million Danish Kroner (US$4.20 million) for the year ending December of 2019. This represents an increase of 2.3% versus 2018, when the company's sales were 26.02 million Danish Kroner. Sales at BioPorto A/S have increased during each of the previous five years (and since 2014, sales have increased a total of 42%). Sales of Royalty saw an increase that was more than double the company's growth rate: sales were up 246.3% in 2019, from 41,000.00 Danish Kroner to 142,000.00 Danish Kroner. BioPorto A/S also saw significant increases in sales in the Ngal Test (up 26.6% to 11.64 million Danish Kroner) . Not all segments of BioPorto A/S experienced an increase in sales in 2019: sales of Other Products and Licenses fell 74.2% to 667,000.00 Danish Kroner.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
BioPorto A/S
  Stock Performance Chart for BioPorto A/S
  Stock Data: Recent Stock Performance:
  Current Price (8/7/2020): 2.55
(Figures in Danish Kroner)
1 Week 0.0%   13 Weeks -4.9%  
4 Weeks -6.6%   52 Weeks -15.0%  
BioPorto A/S Key Data:
  Ticker: BIOPOR Country: Denmark
  Exchanges: CPH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 26,622,000
(Year Ending Jan 2020).
Employees: 34
  Currency: Danish Kroner Market Cap: 446,107,200
  Fiscal Yr Ends: December Shares Outstanding: 174,944,000
  Share Type: B Aktie Closely Held Shares: 38,347,807
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.